{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T07:29:45Z","timestamp":1785914985527,"version":"3.56.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.ejmech.2023.115211","type":"journal-article","created":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T02:29:53Z","timestamp":1676341793000},"page":"115211","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Bestatin analogs-4-quinolinone hybrids as antileishmanial hits: Design, repurposing rational, synthesis, in vitro and in silico studies"],"prefix":"10.1016","volume":"250","author":[{"given":"Ahmed H.E.","family":"Hassan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazem","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trong-Nhat","family":"Phan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moataz A.","family":"Shaldam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chae Hyeon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeon Ju","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Bin","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waleed A.","family":"Bayoumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selwan M.","family":"El-Sayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeonwoo","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suyeon","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joo Hwan","family":"No","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6523-6979","authenticated-orcid":false,"given":"Yong Sup","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2023.115211_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00436-008-0943-2","article-title":"Leishmaniasis treatment\u2014a challenge that remains: a review","volume":"103","author":"Santos","year":"2008","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.ejmech.2023.115211_bib2","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1080\/14756366.2021.1969385","article-title":"Pyrrolidine-based 3-deoxysphingosylphosphorylcholine analogs as possible candidates against neglected tropical diseases (NTDs): identification of hit compounds towards development of potential treatment of Leishmania donovani","volume":"36","author":"Hassan","year":"2021","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115211_bib3","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1080\/14656566.2019.1609940","article-title":"Current and emerging medications for the treatment of leishmaniasis","volume":"20","author":"Chakravarty","year":"2019","journal-title":"Expet Opin. Pharmacother."},{"key":"10.1016\/j.ejmech.2023.115211_bib4","article-title":"Antileishmanial efficacy and pharmacokinetics of DB766-Azole combinations","volume":"62","author":"Joice April","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2023.115211_bib5","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1016\/j.bmcl.2016.03.082","article-title":"Synthesis and pharmacological evaluation of mono-arylimidamides as antileishmanial agents","volume":"26","author":"Zhu","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2023.115211_bib6","doi-asserted-by":"crossref","first-page":"3690","DOI":"10.1128\/AAC.06404-11","article-title":"Evaluation of arylimidamides DB1955 and DB1960 as candidates against visceral leishmaniasis and chagas' disease: in vivo efficacy, acute toxicity, pharmacokinetics, and toxicology studies","volume":"56","author":"Zhu","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2023.115211_bib7","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ejmech.2012.06.058","article-title":"Synthesis, DNA binding and antileishmanial activity of low molecular weight bis-arylimidamides","volume":"55","author":"Banerjee","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115211_bib8","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.3390\/ph15091058","article-title":"Design, rational repurposing, synthesis, in vitro evaluation, homology modeling and in silico study of sulfuretin analogs as potential antileishmanial hit compounds","volume":"15","author":"Hassan","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2023.115211_bib9","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrd3078","article-title":"How to improve R&D productivity: the pharmaceutical industry's grand challenge","volume":"9","author":"Paul","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2023.115211_bib10","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ejmech.2019.07.030","article-title":"Repurposing mosloflavone\/5,6,7-trimethoxyflavone-resveratrol hybrids: discovery of novel p38-\u03b1 MAPK inhibitors as potent interceptors of macrophage-dependent production of proinflammatory mediators","volume":"180","author":"Hassan","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115211_bib11","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1080\/14756366.2019.1699554","article-title":"Reprofiling of pyrimidine-based DAPK1\/CSF1R dual inhibitors: identification of 2,5-diamino-4-pyrimidinol derivatives as novel potential anticancer lead compounds","volume":"35","author":"Farag","year":"2020","journal-title":"J. Enzyme Inhib. Med."},{"key":"10.1016\/j.ejmech.2023.115211_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104121","article-title":"Diarylurea derivatives comprising 2,4-diarylpyrimidines: discovery of novel potential anticancer agents via combined failed-ligands repurposing and molecular hybridization approaches","volume":"103","author":"Farag","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2023.115211_bib13","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1016\/j.drudis.2019.06.014","article-title":"Drug repurposing: a promising tool to accelerate the drug discovery process","volume":"24","author":"Parvathaneni","year":"2019","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2023.115211_bib14","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.drudis.2022.05.026","article-title":"Drug repurposing: an effective strategy to accelerate contemporary drug discovery","volume":"27","author":"Zhan","year":"2022","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2023.115211_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112275","article-title":"A medicinal chemistry perspective of drug repositioning: recent advances and challenges in drug discovery","volume":"195","author":"Pillaiyar","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115211_bib16","article-title":"Computational chemogenomics drug repositioning strategy enables the discovery of epirubicin as a new repurposed hit for plasmodium falciparum and P","volume":"64","author":"Ferreira Let\u00edcia","year":"2020","journal-title":"vivax, Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2023.115211_bib17","doi-asserted-by":"crossref","first-page":"3772","DOI":"10.1080\/07391102.2019.1663263","article-title":"Hit identification and drug repositioning of potential non-nucleoside reverse transcriptase inhibitors by structure-based approach using computational tools (part II)","volume":"38","author":"Cutinho","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.ejmech.2023.115211_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004300","article-title":"A multilayer network approach for guiding drug repositioning in neglected diseases","volume":"10","author":"Berenstein","year":"2016","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ejmech.2023.115211_bib19","doi-asserted-by":"crossref","first-page":"967","DOI":"10.2741\/4629","article-title":"Leishmaniasis treatment: update of possibilities for drug repurposing","volume":"23","author":"Andrade-Neto","year":"2018","journal-title":"Front. Biosci."},{"key":"10.1016\/j.ejmech.2023.115211_bib20","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1016\/j.bmcl.2016.03.103","article-title":"Repurposing strategies for tropical disease drug discovery","volume":"26","author":"Klug","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2023.115211_bib21","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.pt.2016.12.007","article-title":"Repurposing of potent drug candidates for multiparasite targeting","volume":"33","author":"Jain","year":"2017","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ejmech.2023.115211_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105906","article-title":"Searching for drugs for Chagas disease, leishmaniasis and schistosomiasis: a review","volume":"55","author":"Santos","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejmech.2023.115211_bib23","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01422-19","article-title":"In vitro and in vivo characterization of potent antileishmanial methionine aminopeptidase 1 inhibitors","volume":"64","author":"Rodriguez","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2023.115211_bib24","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/med.21774","article-title":"Drug design targeting active posttranslational modification protein isoforms","volume":"41","author":"Meng","year":"2021","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2023.115211_bib25","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41573-020-00114-z","article-title":"Natural products in drug discovery: advances and opportunities","volume":"20","author":"Atanasov","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2023.115211_bib26","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1080\/14756366.2022.2036737","article-title":"Positional scanning of natural product hispidol's ring-B: discovery of highly selective human monoamine oxidase-B inhibitor analogues downregulating neuroinflammation for management of neurodegenerative diseases","volume":"37","author":"Hassan","year":"2022","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115211_bib27","doi-asserted-by":"crossref","first-page":"31339","DOI":"10.1039\/D1RA05817G","article-title":"Investigating the structure\u2013activity relationship of marine natural polyketides as promising SARS-CoV-2 main protease inhibitors","volume":"11","author":"El-Demerdash","year":"2021","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2023.115211_bib28","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.ijbiomac.2018.04.090","article-title":"Structural and functional highlights of methionine aminopeptidase 2 from Leishmania donovani","volume":"115","author":"Bhat","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejmech.2023.115211_bib29","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41598-017-00186-9","article-title":"Methionine aminopeptidase 2 is a key regulator of apoptotic like cell death in Leishmania donovani","volume":"7","author":"Kumar","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2023.115211_bib30","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.3390\/ph14111129","article-title":"Studies of potency and efficacy of an optimized Artemisinin-quinoline hybrid against multiple stages of the plasmodium life cycle","volume":"14","author":"Quadros","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2023.115211_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115973","article-title":"A comprehensive review on the biological interest of quinoline and its derivatives","volume":"32","author":"Matada","year":"2021","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115211_bib32","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ejmech.2017.07.061","article-title":"Quinoline hybrids and their antiplasmodial and antimalarial activities","volume":"139","author":"Hu","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115211_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111860","article-title":"Synthesis and characterization of quinoline-carbaldehyde derivatives as novel inhibitors for leishmanial methionine aminopeptidase 1","volume":"186","author":"Bhat","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115211_bib34","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/cbdd.13783","article-title":"Development of quinoline-based hybrid as inhibitor of methionine aminopeptidase 1 from Leishmania donovani","volume":"97","author":"Bhat","year":"2021","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2023.115211_bib35","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s12272-017-0977-z","article-title":"Design, synthesis and evaluation of alkylphosphocholine-gefitinib conjugates as multitarget anticancer agents","volume":"41","author":"Alam","year":"2018","journal-title":"Arch Pharm. Res. (Seoul)"},{"key":"10.1016\/j.ejmech.2023.115211_bib36","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.bioorg.2018.11.021","article-title":"Design, synthesis and cytotoxicity of chimeric erlotinib-alkylphospholipid hybrids","volume":"84","author":"Alam","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2023.115211_bib37","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.ejmech.2018.10.062","article-title":"Natural products hybrids: 3,5,4\u2032-Trimethoxystilbene-5,6,7-trimethoxyflavone chimeric analogs as potential cytotoxic agents against diverse human cancer cells","volume":"161","author":"Hassan","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115211_bib38","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.3390\/cancers11121927","article-title":"The anti-proliferative activity of the hybrid TMS-TMF-4f compound against human cervical cancer involves Apoptosis mediated by STAT3 inactivation","volume":"11","author":"Hong","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.ejmech.2023.115211_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.857789","article-title":"Mosloflavone-Resveratrol hybrid TMS-HDMF-5z exhibits potent in vitro and in vivo anti-inflammatory effects through NF-\u03baB, AP-1, and JAK\/STAT inactivation","volume":"13","author":"Kim","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2023.115211_bib40","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.288","article-title":"Implication of different domains of the Leishmania major metacaspase in cell death and autophagy","volume":"6","author":"Casanova","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2023.115211_bib41","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ijantimicag.2006.03.021","article-title":"Antileishmanial activity of MDL 28170, a potent calpain inhibitor","volume":"28","author":"d'Avila-Levy","year":"2006","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejmech.2023.115211_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0087659","article-title":"The calpain inhibitor MDL28170 induces the expression of apoptotic markers in leishmania amazonensis promastigotes","volume":"9","author":"Marinho","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2023.115211_bib43","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.parint.2017.06.010","article-title":"The potent cell permeable calpain inhibitor MDL28170 affects the interaction of Leishmania amazonensis with macrophages and shows anti-amastigote activity","volume":"66","author":"Marinho","year":"2017","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.ejmech.2023.115211_bib44","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1017\/S003118201600189X","article-title":"Why calpain inhibitors are interesting leading compounds to search for new therapeutic options to treat leishmaniasis?","volume":"144","author":"Ennes-Vidal","year":"2016","journal-title":"Parasitology"},{"key":"10.1016\/j.ejmech.2023.115211_bib45","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.bmcl.2007.10.097","article-title":"Design and synthesis of 4-quinolinone 2-carboxamides as calpain inhibitors","volume":"18","author":"Nam","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2023.115211_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.tet.2019.130760","article-title":"An expeditious entry to rare tetrahydroimidazo[1,5-c]pyrrolo[1,2-a]pyrimidin-7(8H)-ones: a single-step gateway synthesis of glochidine congeners","volume":"75","author":"Seo","year":"2019","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2023.115211_bib47","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1021\/acs.orglett.8b00098","article-title":"Construction of 8-Azabicyclo[3.2.1]octanes via sequential DDQ-mediated oxidative mannich reactions of N-Aryl pyrrolidines","volume":"20","author":"Jo","year":"2018","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2023.115211_bib48","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s40249-018-0444-1","article-title":"Innovation in neglected tropical disease drug discovery and development","volume":"7","author":"Weng","year":"2018","journal-title":"Infect. Dis. Poverty"},{"key":"10.1016\/j.ejmech.2023.115211_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1008667","article-title":"ProMod3\u2014a versatile homology modelling toolbox","volume":"17","author":"Studer","year":"2021","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.ejmech.2023.115211_bib50","doi-asserted-by":"crossref","first-page":"14741","DOI":"10.1021\/bi051691k","article-title":"Structural basis for the functional differences between type I and type II human methionine aminopeptidases","volume":"44","author":"Addlagatta","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2023.115211_bib51","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1126\/science.282.5392.1324","article-title":"Structure of human methionine aminopeptidase-2 complexed with fumagillin","volume":"282","author":"Liu","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2023.115211_bib52","first-page":"311","article-title":"Metal-ligand bond lengths and strengths: are they correlated?","volume":"228","author":"Nimmermark","year":"2013","journal-title":"Detail. CSD Anal."},{"key":"10.1016\/j.ejmech.2023.115211_bib53","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.3390\/molecules25081980","article-title":"In vitro and in vivo activity of mTOR kinase and PI3K inhibitors against leishmania donovani and trypanosoma brucei","volume":"25","author":"Phan","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2023.115211_bib54","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1\u20132","author":"Abraham","year":"2015","journal-title":"Software"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423001770?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423001770?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:51:51Z","timestamp":1759330311000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523423001770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":54,"alternative-id":["S0223523423001770"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115211","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bestatin analogs-4-quinolinone hybrids as antileishmanial hits: Design, repurposing rational, synthesis, in vitro and in silico studies","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115211","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"115211"}}